July 1, 2024
You are here:  Home  >  Banking & Finance  >  Current Article

MannKind reports loss but record revenue for Q3


Shares of Westlake Village-based MannKind were up 5% during the trading day on Nov. 8, after the company released its earnings for the third quarter of 2022, with revenue and earnings topping analysts’ expectations. MannKind, a biotechnology company that develops treatments for diabetes and pulmonary arterial hypertension, had a net loss of $14.4 million for…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.